A researcher found that using Anthropic’s Claude Opus 4.7, he could break into the website of Front Gate—used by every ...

Mark Stern is launching Intelligent Animation, a studio fusing traditional animation with machine-learning AI tools to ...

GitHub has announced what it said are "breaking changes" coming to npm version 12, one of which turns off install scripts by default to combat software supply chain threats. The changes aim to combat ...

WASHINGTON, June 4 (Reuters) - Commonwealth Fusion Systems, the world's top-funded private firm among those seeking to generate power by replicating the nuclear reaction that takes place in stars, ...

YouTube content creation often feels like a guessing game, but a new strategy empowers creators to use ChatGPT for data-driven success. The AI transforms instinct into evidence by analyzing competitor ...

Helps a desktop AI agent install, inspect, start, troubleshoot, and support the local tool without taking over the browser workflow. Interactive pipeline UI enables iterative processing, local ...

EXCLUSIVE: Veteran literary scout Philippa Donovan wants to reverse engineer the books-to-screen market through her new business, Two Script Studio. The operation will create ‘reverse adaptations‘ to ...

A little over a year ago, MG was leading the relatively normal life of a twentysomething in Scottsdale, Arizona. She worked as a personal assistant and supplemented her income by waiting tables on the ...

Office Scripts in Excel Online provide a practical way to automate repetitive tasks and streamline workflows. By using TypeScript and the Excel Document Object Model (DOM), users can programmatically ...

Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...